Literature DB >> 7611328

Decreased basal tear turnover in patients with untreated primary open-angle glaucoma.

E V Kuppens1, J A van Best, C C Sterk, R J de Keizer.   

Abstract

PURPOSE: To detect whether untreated primary open-angle glaucoma or ocular hypertension is associated with an impaired basal tear turnover.
METHODS: Basal tear turnover was determined by fluorophotometry in 18 patients with newly detected, untreated primary open-angle glaucoma and 29 patients with untreated ocular hypertension. The results were compared with those of 27 age-matched control subjects.
RESULTS: The basal tear turnover in glaucoma patients (mean +/- S.D., 11.4 +/- 3.1%/min) was 22% lower than in patients with ocular hypertension (14.7 +/- 3.0%/min; P = .0007) and 27% lower than in control subjects (15.7 +/- 5.3%/min; P = .001). Tear turnover of patients with ocular hypertension did not differ significantly from that of control subjects (P = .4). The basal tear turnover values were found to decrease with increasing vertical or horizontal cup/disk ratios (P = .004 and P = .008, respectively).
CONCLUSIONS: Primary open-angle glaucoma, but not ocular hypertension, was found to be associated with an impaired basal tear turnover. Dry eye complaints may originate from decreased basal tear turnover as a result of glaucoma drug therapy as well as from primary open-angle glaucoma itself.

Entities:  

Mesh:

Year:  1995        PMID: 7611328     DOI: 10.1016/s0002-9394(14)73757-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

1.  Effects of long-term topical anti-glaucoma medications on meibomian glands.

Authors:  Reiko Arita; Kouzo Itoh; Shuji Maeda; Koshi Maeda; Ayumu Furuta; Atsuo Tomidokoro; Makoto Aihara; Shiro Amano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-18       Impact factor: 3.117

Review 2.  TFOS DEWS II Tear Film Report.

Authors:  Mark D P Willcox; Pablo Argüeso; Georgi A Georgiev; Juha M Holopainen; Gordon W Laurie; Tom J Millar; Eric B Papas; Jannick P Rolland; Tannin A Schmidt; Ulrike Stahl; Tatiana Suarez; Lakshman N Subbaraman; Omür Ö Uçakhan; Lyndon Jones
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

3.  Incidence of ocular side effects of topical beta blockers in the Netherlands.

Authors:  L M van Beek; R J de Keizer; B C Polak; P R Elzenaar; N J van Haeringen; A Kijlstra
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

4.  Frequent association of delayed tear clearance in ocular irritation.

Authors:  P Prabhasawat; S C Tseng
Journal:  Br J Ophthalmol       Date:  1998-06       Impact factor: 4.638

5.  [Influence of dry eye syndrome on glaucoma diagnostic procedures].

Authors:  F Rüfer; C Erb
Journal:  Ophthalmologe       Date:  2012-11       Impact factor: 1.059

6.  German register for glaucoma patients with dry eye. I. Basic outcome with respect to dry eye.

Authors:  Carl Erb; Ulrike Gast; Dieter Schremmer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-07-22       Impact factor: 3.117

Review 7.  Preservative toxicity in glaucoma medication: clinical evaluation of benzalkonium chloride-free 0.5% timolol eye drops.

Authors:  Lauren M Rosin; Nicholas P Bell
Journal:  Clin Ophthalmol       Date:  2013-10-30

8.  Effect of preserved and preservative-free timolol eye drops on tear film stability in healthy Africans.

Authors:  Alex Ilechie; Samuel Abokyi; Gifty Boateng; George Asumeng Koffuor
Journal:  Niger Med J       Date:  2016 Mar-Apr
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.